140 related articles for article (PubMed ID: 29381062)
1. Improved Total Synthesis of Tubulysins and Design, Synthesis, and Biological Evaluation of New Tubulysins with Highly Potent Cytotoxicities against Cancer Cells as Potential Payloads for Antibody-Drug Conjugates.
Nicolaou KC; Erande RD; Yin J; Vourloumis D; Aujay M; Sandoval J; Munneke S; Gavrilyuk J
J Am Chem Soc; 2018 Mar; 140(10):3690-3711. PubMed ID: 29381062
[TBL] [Abstract][Full Text] [Related]
2. Total Synthesis and Biological Evaluation of Natural and Designed Tubulysins.
Nicolaou KC; Yin J; Mandal D; Erande RD; Klahn P; Jin M; Aujay M; Sandoval J; Gavrilyuk J; Vourloumis D
J Am Chem Soc; 2016 Feb; 138(5):1698-708. PubMed ID: 26829208
[TBL] [Abstract][Full Text] [Related]
3. Total synthesis of tubulysin U and its C-4 epimer.
Yang XD; Dong CM; Chen J; Ding YH; Liu Q; Ma XY; Zhang Q; Chen Y
Chem Asian J; 2013 Jun; 8(6):1213-22. PubMed ID: 23576385
[TBL] [Abstract][Full Text] [Related]
4. Total synthesis and biological evaluation of tubulysin U, tubulysin V, and their analogues.
Balasubramanian R; Raghavan B; Begaye A; Sackett DL; Fecik RA
J Med Chem; 2009 Jan; 52(2):238-40. PubMed ID: 19102699
[TBL] [Abstract][Full Text] [Related]
5. Total syntheses of tubulysins.
Shibue T; Hirai T; Okamoto I; Morita N; Masu H; Azumaya I; Tamura O
Chemistry; 2010 Oct; 16(38):11678-88. PubMed ID: 20734394
[TBL] [Abstract][Full Text] [Related]
6. Structural recognition of tubulysin B derivatives by multidrug resistance efflux transporters in human cancer cells.
Stark M; Assaraf YG
Oncotarget; 2017 Jul; 8(30):49973-49987. PubMed ID: 28637003
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of tubulysin analogues.
Courter JR; Hamilton JZ; Hendrick NR; Zaval M; Waight AB; Lyon RP; Senter PD; Jeffrey SC; Burke PJ
Bioorg Med Chem Lett; 2020 Jul; 30(14):127241. PubMed ID: 32527543
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and structure-activity relationship studies of novel tubulysin U analogues--effect on cytotoxicity of structural variations in the tubuvaline fragment.
Shankar SP; Jagodzinska M; Malpezzi L; Lazzari P; Manca I; Greig IR; Sani M; Zanda M
Org Biomol Chem; 2013 Apr; 11(14):2273-87. PubMed ID: 23411563
[TBL] [Abstract][Full Text] [Related]
9. Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines.
Roomi MW; Kalinovsky T; Roomi NW; Rath M; Niedzwiecki A
Oncol Rep; 2012 Jan; 27(1):17-27. PubMed ID: 21947138
[TBL] [Abstract][Full Text] [Related]
10. Introducing Glycolinkers for the Functionalization of Cytotoxic Drugs and Applications in Antibody-Drug Conjugation Chemistry.
Ekholm FS; Pynnönen H; Vilkman A; Pitkänen V; Helin J; Saarinen J; Satomaa T
ChemMedChem; 2016 Nov; 11(22):2501-2505. PubMed ID: 27786414
[TBL] [Abstract][Full Text] [Related]
11. The Recent Developments of ADCs with the Tubulysins as the Payloads.
Xiangrong X; Yao L; Yao A
Mini Rev Med Chem; 2023; 23(18):1797-1805. PubMed ID: 36825713
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and antitumor activity evaluation of pretubulysin analogs.
Xu X; Fan M; Qi J; Yao L
Chem Biol Drug Des; 2021 Sep; 98(3):341-351. PubMed ID: 33930251
[TBL] [Abstract][Full Text] [Related]
13. Structure-Cytotoxicity Relationships of Analogues of N
Toader D; Wang F; Gingipalli L; Vasbinder M; Roth M; Mao S; Block M; Harper J; Thota S; Su M; Ma J; Bedian V; Kamal A
J Med Chem; 2016 Dec; 59(23):10781-10787. PubMed ID: 27809515
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel amino-substituted xanthenones and benzo[b]xanthenones: evaluation of their antiproliferative activity and their ability to overcome multidrug resistance toward MES-SA/D x 5 cells.
Kostakis IK; Pouli N; Marakos P; Skaltsounis AL; Pratsinis H; Kletsas D
Bioorg Med Chem; 2006 May; 14(9):2910-34. PubMed ID: 16376546
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Biological Evaluation of a Carbamate-Containing Tubulysin Antibody-Drug Conjugate.
Cheng H; Cong Q; Dervin D; Stevens A; Vemuri K; Huber M; Juliano J; Cuison S; Sung J; Passmore D; Chong C; Greenbaum M; Kwok E; Jiang J; Pan C; Rao-Naik C; Rangan V; Kempe T; Tatum A; Deshpande S; Cardarelli P; Vite G; Gangwar S
Bioconjug Chem; 2020 Oct; 31(10):2350-2361. PubMed ID: 32881482
[TBL] [Abstract][Full Text] [Related]
16. Pretubulysin, a potent and chemically accessible tubulysin precursor from Angiococcus disciformis.
Ullrich A; Chai Y; Pistorius D; Elnakady YA; Herrmann JE; Weissman KJ; Kazmaier U; Müller R
Angew Chem Int Ed Engl; 2009; 48(24):4422-5. PubMed ID: 19431172
[TBL] [Abstract][Full Text] [Related]
17. Total Synthesis in Search of Potent Antibody-Drug Conjugate Payloads. From the Fundamentals to the Translational.
Nicolaou KC; Rigol S
Acc Chem Res; 2019 Jan; 52(1):127-139. PubMed ID: 30575399
[TBL] [Abstract][Full Text] [Related]
18. Simplified pretubulysin derivatives and their biological effects on cancer cells.
Kubisch R; von Gamm M; Braig S; Ullrich A; Burkhart JL; Colling L; Hermann J; Scherer O; Müller R; Werz O; Kazmaier U; Vollmar AM
J Nat Prod; 2014 Mar; 77(3):536-42. PubMed ID: 24437936
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, and Cytotoxic Evaluation of Novel Tubulysin Analogues as ADC Payloads.
Leverett CA; Sukuru SC; Vetelino BC; Musto S; Parris K; Pandit J; Loganzo F; Varghese AH; Bai G; Liu B; Liu D; Hudson S; Doppalapudi VR; Stock J; O'Donnell CJ; Subramanyam C
ACS Med Chem Lett; 2016 Nov; 7(11):999-1004. PubMed ID: 27882198
[TBL] [Abstract][Full Text] [Related]
20. Enhancing the therapeutic range of a targeted small-molecule tubulysin conjugate for folate receptor-based cancer therapy.
Leamon CP; Reddy JA; Vlahov IR; Dorton R; Bloomfield A; Vetzel M; Klein PJ; Westrick E; Xu LC; Wang Y
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1151-1160. PubMed ID: 28451831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
